Scholar Rock Holding (SRRK) Total Non-Current Liabilities (2017 - 2021)

Scholar Rock Holding's (SRRK) quarterly Total Non-Current Liabilities came in at $115.4 million in Q2 2021, down 3.87% quarter-over-quarter from $120.0 million in Q1 2021.

Scholar Rock Holding (SRRK) Total Non-Current Liabilities (2017 - 2021) Analysis & Trends

Scholar Rock Holding's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $115.4 million for Q2 2021.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $115.4 million in Q2 2021; TTM through Jun 2021 was $115.4 million, a N/A change from a year earlier, with the FY2020 full-year figure at $127.5 million, up 52.78% from the prior year.
  • Total Non-Current Liabilities fell to $115.4 million in Q2 2021 per SRRK's latest filing, from $120.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $127.5 million in Q4 2020 and bottomed at $5.9 million in Q4 2017.
  • The 4-year median for Total Non-Current Liabilities is $115.4 million (2021), against an average of $90.5 million.
  • Biggest YoY gain for Total Non-Current Liabilities was 52.78% in 2020; the steepest drop was 52.78% in 2020.
  • Year by year, Total Non-Current Liabilities stood at $5.9 million in 2017, then soared by 1317.16% to $83.5 million in 2019, then jumped by 52.78% to $127.5 million in 2020, then fell by 9.52% to $115.4 million in 2021.
  • Per Business Quant, the three latest SRRK Total Non-Current Liabilities figures stand at $115.4 million (Q2 2021), $120.0 million (Q1 2021), and $127.5 million (Q4 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 115.39 Mn
Mar 31, 2021 120.04 Mn
Dec 31, 2020 127.53 Mn
Dec 31, 2019 83.47 Mn
Dec 31, 2017 5.89 Mn